• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Evgen portfolio update on core field of cancer, ‘the R&D is entirely on plan and on budget’

steve | 22 July 2021
Categories: Videos

Post navigation

← Evgen Pharma updates on the ‘STAR’ trial for Covid-19, Glioma research and key breast cancer drug
Evgen Pharma presents 2022 clinical trials plans and progress with US and UK regulators →
Copyright© 2026   ICO Reg: ZB396415
  • Website Privacy Policy and Cookie Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch